INCY Incyte Corporation
Healthcare$97.10-0.06%ClosedMarket Cap: $19.40B
As of 2026-05-26
Valuation
P/E (TTM)
14.86
PEG
0.00
P/B
3.49
P/S
3.62
EV/EBITDA
8.54
DCF Value
$120.06
FCF Yield
7.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
92.5%
Operating Margin
27.1%
Net Margin
26.7%
ROE
29.3%
ROA
19.5%
ROIC
20.1%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.27B | 91.8% | $324.2M | $303.3M | $— | — |
| Q4 null | $1.51B | 92.0% | $384.0M | $299.3M | $— | — |
| FY null | $5.14B | 92.8% | $1.34B | $1.29B | $— | — |
| Q3 null | $1.37B | 92.8% | $431.3M | $424.2M | $— | — |
| Q2 null | $1.22B | 93.5% | $310.8M | $405.0M | $— | — |
| Q1 null | $1.05B | 93.0% | $216.7M | $158.2M | $— | — |
| Q4 null | $1.18B | 92.5% | $297.4M | $201.2M | $— | — |
| FY null | $4.24B | 92.6% | $101.3M | $32.6M | $— | — |
| Q3 null | $1.14B | 92.4% | $146.1M | $106.5M | $— | — |
| Q2 null | $1.04B | 92.7% | $-478.1M | $-444.6M | $— | — |
| Q1 null | $880.9M | 91.2% | $90.4M | $169.5M | $— | — |
| Q4 2023 | $1.01B | 91.5% | $205.2M | $201.1M | $0.89 | — |